Kristin Klemmetsby Solli - Search Results

Year	Number of Results
2016	2
2017	1
2018	1
2019	2
2020	2
2021	3
2022	3
2023	0

1

Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study.

Latif ZE, Šaltyte Benth J, Solli KK, Opheim A, Kunoe N, Krajci P, Sharma-Haase K, Tanum L. Latif ZE, et al. Among authors: solli kk. JAMA Psychiatry. 2019 Feb 1;76(2):127-134. doi: 10.1001/jamapsychiatry.2018.3537. JAMA Psychiatry. 2019. PMID: 30566177 Free PMC article. Clinical Trial.

2

Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.

Tanum L, Solli KK, Latif ZE, Benth JŠ, Opheim A, Sharma-Haase K, Krajci P, Kunøe N. Tanum L, et al. Among authors: solli kk. JAMA Psychiatry. 2017 Dec 1;74(12):1197-1205. doi: 10.1001/jamapsychiatry.2017.3206. JAMA Psychiatry. 2017. PMID: 29049469 Free PMC article. Clinical Trial.

3

Patients' experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study.

Marciuch A, Brenna IH, Weimand B, Solli KK, Tanum L, Røstad BK, Birkeland B. Marciuch A, et al. Among authors: solli kk. Addict Sci Clin Pract. 2022 Jul 18;17(1):36. doi: 10.1186/s13722-022-00317-2. Addict Sci Clin Pract. 2022. PMID: 35850782 Free PMC article. Clinical Trial.

4

Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone.

Karlsson AT, Vederhus JK, Clausen T, Weimand B, Solli KK, Tanum L. Karlsson AT, et al. Among authors: solli kk. Int J Environ Res Public Health. 2022 Sep 11;19(18):11435. doi: 10.3390/ijerph191811435. Int J Environ Res Public Health. 2022. PMID: 36141709 Free PMC article.

5

'Not at all what I had expected': Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study.

Brenna IH, Marciuch A, Birkeland B, Veseth M, Røstad B, Løberg EM, Solli KK, Tanum L, Weimand B. Brenna IH, et al. Among authors: solli kk. J Subst Abuse Treat. 2022 May;136:108667. doi: 10.1016/j.jsat.2021.108667. Epub 2021 Nov 27. J Subst Abuse Treat. 2022. PMID: 34865937 Free article.

6

Interest in Extended Release Naltrexone among Opioid Users.

Sharma Haase K, Kunøe N, Opheim A, Gaulen Z, Njå AM, Latif ZE, Solli KK, Tanum L. Sharma Haase K, et al. Among authors: solli kk. Eur Addict Res. 2016;22(6):301-305. doi: 10.1159/000447964. Epub 2016 Jul 20. Eur Addict Res. 2016. PMID: 27434137

7

Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial.

Opheim A, Gaulen Z, Solli KK, Latif ZE, Fadnes LT, Benth JŠ, Kunøe N, Tanum L. Opheim A, et al. Among authors: solli kk. Am J Addict. 2021 Sep;30(5):453-460. doi: 10.1111/ajad.13151. Am J Addict. 2021. PMID: 34487395 Clinical Trial.

8

Levels of Impulsivity, Hyperactivity, and Inattention and the Association with Mental Health and Substance Use Severity in Opioid-Dependent Patients Seeking Treatment with Extended-Release Naltrexone.

Karlsson AT, Vederhus JK, Clausen T, Weimand B, Solli KK, Tanum L. Karlsson AT, et al. Among authors: solli kk. J Clin Med. 2021 Sep 30;10(19):4558. doi: 10.3390/jcm10194558. J Clin Med. 2021. PMID: 34640572 Free PMC article.

9

Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trial.

Solli KK, Latif ZE, Opheim A, Krajci P, Sharma-Haase K, Benth JŠ, Tanum L, Kunoe N. Solli KK, et al. Addiction. 2018 Oct;113(10):1840-1849. doi: 10.1111/add.14278. Epub 2018 Jun 22. Addiction. 2018. PMID: 29806872

10

Adapting treatment length to opioid-dependent individuals' needs and preferences: A 2-year follow-up to a 1-year study of extended-release naltrexone.

Solli KK, Opheim A, Latif ZE, Krajci P, Benth JŠ, Kunoe N, Tanum L. Solli KK, et al. Addiction. 2020 Dec 18;116(8):2084-93. doi: 10.1111/add.15378. Online ahead of print. Addiction. 2020. PMID: 33338285 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results